AdaptHealth Sells Diabetes Health Business to Cardinal Health for $235M Cash
AHCO sits 31% above its 52-week low of $8.505.
Summary
AdaptHealth Corp. has entered into a definitive agreement to sell its Diabetes Health business to Cardinal Health for $235 million in cash, a move to refocus on its core sleep and respiratory segments and accelerate deleveraging.
Key Events · M&A and Partnerships · AHCO
-
Diabetes Health Business Sold for $235M
AdaptHealth signed an asset purchase agreement on July 19, 2026, to sell substantially all assets of its Diabetes Health business to RGH Enterprises, LLC, a Cardinal Health subsidiary, for $235 million in cash, subject to a net working capital adjustment.
-
Strategic Portfolio Reshaping
The divestiture is the most significant step in a multi-year effort to focus on core sleep, respiratory, and home medical equipment businesses, with the Diabetes unit to be reported as a discontinued operation.
-
Capital Allocation and Deleveraging
Proceeds will be used for reinvestment in core businesses and debt reduction, accelerating AdaptHealth's deleveraging trajectory and strengthening its balance sheet.
-
Transaction Structure and Protections
The deal includes an $8 million adjustment escrow and an $18.8 million indemnification escrow. A $9.4 million termination fee is payable by the buyer if the deal fails due to antitrust clearance issues.
Analysis · AHCO · Industrial Applications And Services
AdaptHealth is divesting its Diabetes Health business to Cardinal Health for $235 million in cash, a deal that sharpens its focus on core sleep and respiratory segments while providing capital for debt reduction. The sale represents a significant portfolio reshaping — the Diabetes unit is being treated as a discontinued operation going forward. The transaction is subject to HSR clearance and other customary conditions, with a $9.4 million termination fee payable by the buyer if antitrust clearance fails. For a company with a market cap around $1.5 billion, this is a material asset sale that will meaningfully alter its revenue mix and balance sheet.
How filings like this one have moved
In the 30 days to Sep 21, 2026, 34.9% of the 999 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AHCO was trading at $11.17 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $8.51 to $13.43. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.